3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Keratosis, Actinic
12
Head and Neck Neoplasms
3
Condylomata Acuminata
3
Neoplasms
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Exanthema
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Wounds and Injuries
1
Warts
1
Virus Diseases
1
Usual Type Vulval Intraepithelial Neoplasia (uVIN)
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Sexually Transmitted Diseases
1
Radiodermatitis
1
Parapsoriasis
1
Papillomavirus Infections
1
Non-Muscle Invasive Bladder Neoplasms
1
Non-Melanoma Skin Cancers
1
Lymphoma, Follicular
1
Keratosis, Seborrheic
1
Hypogonadism
1
Hemangioma, Cavernous
1
Hemangioma
1
Interventions
Morphine
2
ziconotide
1
rimabotulinumtoxinB
1
Syringes
1
Psilocybin
1
Massage
1
Low-Level Light Therapy
1
Lidocaine
1
Gels
1
Ethanol
1
Erythromycin
1
Botulinum Toxins, Type A
1
Bandages
1
Bacitracin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Wounds and Injuries
×
Gels
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled